Product Description: Mal-amido-PEG8-Val-Ala-PAB-SG3199 (Compound B7-H4-ADC) is a Drug-Linker Conjugates for ADC. Mal-amido-PEG8-Val-Ala-PAB-SG3199 inhibits proliferation of cancer cells, induces apoptosis, arrests the cell cycle and damages the DNA[1].
Applications: Cancer-programmed cell death
Formula: C76H103N9O22
References: [1]Gitto SB, et al., A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression. Clin Cancer Res. 2024 Apr 15;30(8):1567-1581.
Molecular Weight: 1494.68
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Drug-Linker Conjugates for ADC